Addus HomeCare Corporation (ADUS) analyst actions
Rating and price-target actions on ADUS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ADUS overview →
No ADUS analyst action events in the measured window.
Nothing matched in the current window — the ADUS overview has every event we measure for this name.
Get an email when ADUS moves on news →Keep exploring
More ADUS: earnings → · SEC filings → · ADUS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| FORTY SEVEN (FTSV) | 257 | +0.01% | 51% |
| SELLAS Life Sciences Group, Inc. (SLS) | 257 | -0.63% | 42% |
| Celldex Therapeutics, Inc. (CLDX) | 256 | +0.04% | 57% |
| Prothena Corporation plc - Ordinary Shares (PRTA) | 256 | -0.04% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.